FTO and lung cancer: Indeed, the percentage of m6A‐modified RNA was significantly lower in tumour tissues compared with adjacent non‐tumour tissues (Figure 3D), whereas m6Am levels were not significantly different (Figure S3D); these results are consistent with an m6A‐specific and ‐dependent role for FTO in lung cancer proliferation.